Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in lupus

Angie Davidson

25 May 2021

taiwan

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in lupus

Hydroxychloroquine is widely used to treat certain viral and rheumatic diseases including systemic lupus erythematosus. Cardiac arrhythmia is an important safety issue with hydroxychloroquine. The aim of this study was to investigate whether hydroxychloroquine increases new-onset arrhythmia among patients with systemic lupus erythematosus.

Angie Davidson

10 April 2019

taiwan

Risk of severe herpes simplex virus infection in systemic lupus erythematosus

Angie Davidson

10 April 2019

taiwan

Risk of severe herpes simplex virus infection in systemic lupus erythematosus

Patients with systemic lupus erythematosus (SLE) are susceptible to herpes simplex virus (HSV) infection, which occasionally leads to severe complications including meningoencephalitis and keratitis. However, few attempts to analyse the associated incidence and risk factors have been made.

THE CONTENT ON THIS WEBSITE SHOULD NOT BE SEEN AS SUBSTITUTE FOR MEDICAL ADVICE. IF YOU HAVE, OR THINK YOU MAY HAVE, LUPUS, ALWAYS SEEK ADVICE FROM A QUALIFIED PHYSICIAN. FIND OUT MORE IN OUR TERMS OF USE.